Evaluation of Intrastromal Injection of Voriconazole as a Therapeutic Adjunctive for the Management of Deep Recalcitrant Fungal Keratitis

American Journal of Ophthalmology

Volumn 146, Issue 1, 2008, Pages

  Prakash, Gaurav ^a   Sharma, Namrata ^a   Goel, Manik ^a   Titiyal, Jeewan S ^a   Vajpayee, Rasik B ^a,b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NATAMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; VORICONAZOLE;

ADULT; ARTICLE; BACTERIUM CULTURE; CASE REPORT; CLINICAL EVALUATION; CORNEA STROMA; CORNEA ULCER; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; EYE INJURY; HUMAN; INTRACORNEAL DRUG ADMINISTRATION; KERATOMYCOSIS; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TERTIARY HEALTH CARE; UNIVERSITY HOSPITAL; VISUAL ACUITY;

EID: 45449084394     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2008.02.023     Document Type: Article

References (12)

1. Yoon K.C., Jeong I.Y., Im S.K., Chae H.J., and Yang S.Y. Therapeutic effect of intracameral amphotericin B injection in the treatment of fungal keratitis. Cornea 26 (2007) 814-818
2. Yilmaz S., Ture M., and Maden A. Efficacy of intracameral amphotericin B injection in the management of refractory keratomycosis and endophthalmitis. Cornea 26 (2007) 398-402
3. Kuriakose T., Kothari M., Paul P., Jacob P., and Thomas R. Intracameral amphotericin B injection in the management of deep keratomycosis. Cornea 21 (2002) 653-656
4. Ghate D., and Edelhauser H.F. Ocular drug delivery. Expert Opin Drug Deliv 3 (2006) 275-287
5. Garcia-Valenzuela E., and Song C.D. Intrastromal injection of amphothericin B for recurrent fungal keratitis and endophthalmitis. Arch Ophthalmol 123 (2005) 1721-1723
6. Freda R. Use of oral voriconazole as adjunctive treatment of severe corneal fungal infection: case report. Arq Bras Oftalmol 69 (2006) 431-434
7. Polizzi A., and Sinischalchi C. Effect of voriconazole on a corneal abscess caused by Fusarium. Acta Ophthalmol Scand 82 (2004) 762-764
8. Jhanji V., Sharma N., Mannan R., Titiyal J.S., and Vajpayee R.B. Management of tunnel fungal infection with voriconazole. J Cataract Refract Surg 33 (2007) 915-917
9. Breit S.M., Hariprasad S.M., Mieler W.F., Shah G.K., Mills M.D., and Grand M.G. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. Am J Ophthalmol 139 (2005) 135-140
10. Diekema D.J., Messer S.A., Hollis R.J., Jones R.N., and Pfaller M.A. Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. J Clin Microbiol 41 (2003) 3623-3626
11. Pfaller M.A., Messer S.A., Hollis R.J., Jones R.N., and Diekema D.J. In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp. Antimicrob Agents Chemother 46 (2002) 1723-1727
12. Gao H., Pennesi M., Shah K., et al. Safety of intravitreal voriconazole: electroretinographic and histopathologic studies. Trans Am Ophthalmol Soc 101 (2003) 183-189